Online-adaptive versus robust IMPT for prostate cancer: How much can we gain?

Thyrza Jagt; Sebastiaan Breedveld; Rens Haveren; Ben Heijmen; Mischa Hoogeman

doi:10.1016/j.radonc.2020.07.054

Online-adaptive versus robust IMPT for prostate cancer: How much can we gain?

Thyrza Jagt
, Sebastiaan Breedveld
, Rens Haveren
, Ben Heijmen
, Mischa Hoogeman

Radiotherapy

Research output: Contribution to journal › Article › Academic › peer-review

19 Citations (Scopus)

58 Downloads (Pure)

Original language	English
Pages (from-to)	228-233
Number of pages	6
Journal	Radiotherapy and Oncology
Volume	151
DOIs	https://doi.org/10.1016/j.radonc.2020.07.054
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC OR-01

Access to Document

10.1016/j.radonc.2020.07.054

Repub_130841_O-A.pdfFinal published version, 1.15 MB

http://hdl.handle.net/1765/130841

Cite this

@article{1ed1948654034853a0a0c0bafe429846,

title = "Online-adaptive versus robust IMPT for prostate cancer: How much can we gain?",

author = "Thyrza Jagt and Sebastiaan Breedveld and Rens Haveren and Ben Heijmen and Mischa Hoogeman",

year = "2020",

doi = "10.1016/j.radonc.2020.07.054",

language = "English",

volume = "151",

pages = "228--233",

journal = "Radiotherapy and Oncology",